David M. Reese - Nov 28, 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Role
EVP, Research and Development
Signature
/s/ David M. Reese
Stock symbol
AMGN
Transactions as of
Nov 28, 2023
Transactions value $
$0
Form type
4
Date filed
11/29/2023, 08:44 PM
Previous filing
May 9, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Gift $0 -165 -0.3% $0.00 54.2 K Nov 28, 2023 Direct F1, F2, F3

Explanation of Responses:

Id Content
F1 The transaction reported involved gifts by the reporting person of shares of the Company's common stock to six charitable organizations.
F2 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3 These shares include 633 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.